FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 2053603 · Received April 13, 2011

Report

Report Number
2124215-2011-04346
Event Type
Malfunction
Date Received
April 13, 2011
Date of Event
March 1, 2011
Report Date
November 8, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
PMA / PMN Number
P960040
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

TO DATE, INFORMATION SUGGESTS THAT THESE MEDICAL DEVICES REMAIN ACTIVELY IN SERVICE. AS NEW INFORMATION WOULD BECOME AVAILABLE, THIS REPORT WILL BE FURTHER EVALUATED AND UPDATED. THE INVESTIGATION IS CONSIDERED STILL OPEN AT THIS TIME.

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE TRANSVENOUS RIGHT VENTRICULAR (RV) LEAD IN ASSOCIATION WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) WAS DETERMINED TO HAVE INTERMITTENT OUT-OF-RANGE SHOCK IMPEDANCE, OCCASIONALLY EXCEEDING 125 OHMS SHOCK IMPEDANCE. AT IMPLANT, THIS LEAD WAS AT 80 OHMS SHOCK IMPEDANCE. ALL OTHER MEASUREMENTS WERE WITHIN NORMAL LIMITS. THE SOURCE OF THE INTERMITTENT RISE IN IMPEDANCE WAS NOT KNOWN AT THE TIME OF THIS INITIAL REPORT. TROUBLESHOOTING WAS TO BE DONE. THERE WERE NO OBSERVED ADVERSE PATIENT EFFECTS ASSOCIATED WITH THIS CLINICAL OBSERVATION.

Description of Event or Problem · 1

ADDITIONAL INFORMATION INDICATES THAT THIS PATIENT WAS EVALUATED IN THE CLINIC AND THE SHOCK IMPEDANCE MEASUREMENT WAS 123 OHMS. THE PHYSICIAN HAS ORDERED THAT THE PATIENT CONTINUES TO BE MONITORED AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 59 YR 4470| 0180| E110